- Patent Title: Enhancing the therapeutic activity of immune checkpoint inhibitor
-
Application No.: US15435425Application Date: 2017-02-17
-
Publication No.: US10906977B2Publication Date: 2021-02-02
- Inventor: Peter C. Brooks , Jennifer M. Caron , Liangru Contois
- Applicant: Maine Medical Center Research Institute
- Applicant Address: US ME Scarborough
- Assignee: Maine Medical Center Research Institute
- Current Assignee: Maine Medical Center Research Institute
- Current Assignee Address: US ME Scarborough
- Agency: Mintz Levin Cohn Ferris Glovsky and Popeo, P.C.
- Main IPC: A61K39/395
- IPC: A61K39/395 ; A61K39/00 ; C07K16/28 ; A61K38/39 ; A61K45/06 ; C07K16/18
Abstract:
The present invention provides antagonists and methods of use thereof in the treatment of cancer and abnormal immune suppression diseases.
Public/Granted literature
- US20170240638A1 ENHANCING THE THERAPEUTIC ACTIVITY OF IMMUNE CHECKPOINT INHIBITOR Public/Granted day:2017-08-24
Information query
